Hospital Acquired Infection Control Market Size, Share, Industry Trends and Forecast to 2030

Hospital Acquired Infection Control Market Size & CAGR in 2021:

The global hospital acquired infection control market is projected to have a compound annual growth rate (CAGR) of 6.2% from 2021 to 2028. With this growth rate, the market is expected to reach a size of USD 23.5 billion by the year 2028.

COVID-19 Impact on Hospital Acquired Infection Control Market:

The COVID-19 pandemic has had a significant impact on the hospital acquired infection control market. With the increased focus on hygiene and infection prevention in healthcare settings, the demand for infection control products and services has surged. Hospitals and healthcare facilities have implemented stricter protocols to prevent the spread of infections, leading to a greater emphasis on infection control measures.

Hospital Acquired Infection Control Dynamics:

The dynamics of the hospital acquired infection control market are influenced by factors such as the increasing prevalence of healthcare-associated infections, the growing awareness regarding infection control practices, and the implementation of stringent regulations and guidelines by government bodies and healthcare organizations. The market is also driven by the development of advanced infection control products and technologies to combat emerging pathogens.

Segments and Related Analysis:

The hospital acquired infection control market can be segmented based on product type, end-user, and region. Product segments include disinfectants, sterilization products, personal protective equipment, and surveillance and monitoring devices. End-users of infection control products and services include hospitals, clinics, ambulatory surgical centers, and long-term care facilities. Regionally, the market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

By Region Analysis:

In 2021, North America held the largest market share in the global hospital acquired infection control market, followed by Europe and Asia Pacific. The presence of well-established healthcare infrastructure, stringent regulations, and high awareness regarding infection control practices drive the market in these regions. However, the Asia Pacific region is expected to witness the fastest growth due to increasing healthcare expenditure, rising incidence of healthcare-associated infections, and the growing focus on patient safety.

Key Market Players and Competitive Landscape:

Some of the key players in the hospital acquired infection control market include 3M Company, Steris Corporation, Cantel Medical Corporation, Advanced Sterilization Products Services Inc., Ecolab Inc., and bioMerieux SA. These companies focus on product innovation, strategic collaborations, and mergers and acquisitions to strengthen their market presence and expand their product portfolios.

Recent Happenings in the Hospital Acquired Infection Control Market:

- In 2021, Ecolab Inc. introduced a new line of disinfectant products specifically designed for healthcare settings to tackle emerging pathogens and prevent hospital-acquired infections.

- Steris Corporation collaborated with leading healthcare facilities to implement advanced infection control protocols and technologies to enhance patient safety and reduce the risk of healthcare-associated infections.

- 3M Company launched a series of personal protective equipment for healthcare professionals to ensure the highest standards of infection prevention and control during the COVID-19 pandemic.

- Cantel Medical Corporation acquired a major stake in a technology startup specializing in surveillance and monitoring devices for infection control, aiming to revolutionize the way healthcare facilities track and manage infections.